Insmed Inc (NASDAQ: INSM) on Friday, soared 1.18% from the previous trading day, before settling in for the closing price of $190.96. Within the past 52 weeks, INSM’s price has moved between $60.40 and $197.08.
A company in the Healthcare sector has dropped its sales by -13.12% annually for the last half of the decade. The company achieved an average annual earnings per share of -10.26%. With a float of $209.23 million, this company’s outstanding shares have now reached $212.58 million.
Insmed Inc (INSM) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Insmed Inc is 1.94%, while institutional ownership is 100.80%. The most recent insider transaction that took place on Nov 12 ’25, was worth 5,820,061. In this transaction Chief People Strategy Officer of this company sold 30,000 shares at a rate of $194.00, taking the stock ownership to the 36,461 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Chief Medical Officer sold 31,226 for $189.68, making the entire transaction worth $5,922,795. This insider now owns 83,111 shares in total.
Insmed Inc (INSM) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.32 earnings per share (EPS) for the period falling under the consensus outlook (set at -1.16) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 56.84% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Insmed Inc (INSM) is currently performing well based on its current performance indicators. A quick ratio of 4.34 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 92.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.18, a number that is poised to hit -1.26 in the next quarter and is forecasted to reach -3.47 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Let’s dig in a bit further. During the last 5-days, its volume was 2.03 million. That was inferior than the volume of 2.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.57%.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 95.88%, which indicates a significant increase from 87.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 8.08 in the past 14 days, which was higher than the 4.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $162.35, while its 200-day Moving Average is $107.33. However, in the short run, Insmed Inc’s stock first resistance to watch stands at $197.93. Second resistance stands at $202.63. The third major resistance level sits at $207.82. If the price goes on to break the first support level at $188.03, it is likely to go to the next support level at $182.84. The third support level lies at $178.14 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
Market capitalization of the company is 41.21 billion based on 213,273K outstanding shares. Right now, sales total 363,710 K and income totals -913,770 K. The company made 142,340 K in profit during its latest quarter, and -370,020 K in sales during its previous quarter.
